Diffuse Large B-Cell Lymphoma | Oncology Today with Dr Neil Love: Advances in Diffuse Large B-Cell Lymphoma

Research To Practice | Oncology Videos · Feb 6, 2023 · 43m

Featuring an interview with Dr Gilles Salles, including the following topics:

Biology underlying B-cell lymphomas, role of Bruton tyrosine kinase (BTK) inhibitors in lymphomas and reason for cure in diffuse large B-cell lymphoma (DLBCL) versus indolent lymphomas (0:00)

Efficacy, tolerability and optimal sequencing of selinexor, polatuzumab vedotin/bendamustine/rituximab, tafasitamab/lenalidomide and loncastuximab tesirine for DLBCL (6:32)

Ongoing trials evaluating selinexor, tafasitamab/lenalidomide and loncastuximab tesirine for DLBCL (14:24)

Managing cytokine release syndrome associated…